Výsledky vyhledávání - "Ruth Geraldes"

Akademický článek

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK

Autor: Alan J Thompson, Charles Wade, Nevin John, Jeremy Chataway, Gavin Giovannoni, Rachael Hunter, Sreedharan Harikrishnan, Floriana De Angelis, Olga Ciccarelli, Eli Silber, John Greenwood, Thomas Williams, Martin Duddy, Basil Sharrack, Annie Hawton, Siddharthan Chandran, Sue Pavitt, Paul Gallagher, Ian Galea, Jennifer M Nicholas, Tarunya Arun, Miriam Mattoscio, Richard Nicholas, Neil Robertson, Carolyn Young, Jeremy Hobart, David Rog, Owen Pearson, Anisha Doshi, Timothy Harrower, Leonora Fisniku, Ruth Geraldes, Nikos Evangelou, Judy Beveridge, Matthew Craner, Don Mahad, Stefano Pluchino, Suresh Chhetri, Susan Tebbs, Marie Braisher, Seema Kalra, Charles Hillier, Chris Frost, Gavin McDonnell, Stuart J Nixon, Helen L Ford, Jeban Ganesalingam, Claire Rice, Alberto Calvi, Cord Spilker, Abdullah Shehu, Martin Lee, James Blackstone, Alessia Bianchi, Agne Straukiene, Gil Barton, Fayyaz Ahmed, Dawn Lyle, Ekaterina Bordea, Sean Apap Mangion, Rachel Merry, Elisabeth Jarman

Publikováno v: BMJ Open, Vol 14, Iss 9 (2024)

Introduction There remains a high unmet need for disease-modifying therapies that can impact disability progression in secondary progressive multiple sclerosis (SPMS). Following positive results of the phase 2 MS-STAT study, the MS-STAT2 phase 3 tria

Externí odkaz: https://doaj.org/article/69619bde66e34a6986cbeaf0b8bdc802

Zobrazit plný text záznamu

Akademický článek

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

Comorbidities in patients with multiple sclerosis (MS) and antibody-mediated diseases of the central nervous system (CNS) including neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein (MOG)-antibody-associated dise

Externí odkaz: https://doaj.org/article/2b740f34241942d389bbfe03e7b0adef

Zobrazit plný text záznamu

Akademický článek

Usefulness of EEG for the differential diagnosis of possible transient ischemic attack

Autor: Carla Bentes, Patrícia Canhão, Ana Rita Peralta, Pedro Viana, Ana Catarina Fonseca, Ruth Geraldes, Teresa Pinho e Melo, Teresa Paiva, José Manuel Ferro

Publikováno v: Clinical Neurophysiology Practice, Vol 3, Iss , Pp 11-19 (2018)

Objective: EEG value in possible transient ischemic attacks (TIA) is unknown. We aim to quantify focal slow wave activity (FSWA) and epileptiform activity (EA) frequency in possible TIA, and to analyse its contribution to the final diagnosis of seizu

Externí odkaz: https://doaj.org/article/b7a4529d151f4106902d058b5ea03ad5

Zobrazit plný text záznamu

Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease

Autor: Valentina Camera, Romina Mariano, Silvia Messina, Ricarda Menke, Ludovica Griffanti, Matthew Craner, Maria I Leite, Massimiliano Calabrese, Stefano Meletti, Ruth Geraldes, Jacqueline A Palace

Publikováno v: Brain Communications. 5

Fatigue is frequently reported by patients with multiple sclerosis, aquaporin-4-antibody neuromyelitis optica spectrum disorder and myelin-oligodendrocyte-glycoprotein antibody disease; thus they could share a similar pathophysiological mechanism. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e938fad9ba8bd47ebac0406c37d0d62a
https://doi.org/10.1093/braincomms/fcad107

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání